ETS2 anticorps (AA 146-173)

N° du produit ABIN653803

Détail du produit anti-ETS2 anticorps

Antigène: ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))

Épitope: AA 146-173

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ETS2 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: B, M

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ETS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 146-173 amino acids from the Central region of human ETS2.

Clone: RB24588

Isotype: IgG

Information d'application

Indications d'application: WB: 1:2000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Références pour anticorps anti-ETS2 (ABIN653803)

Kabbout, Garcia, Fujimoto, Liu, Woods, Chow, Mendoza, Momin, James, Solis, Behrens, Lee, Wistuba, Kadara: "ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 13, pp. 3383-95, (2013) (PubMed).

Détails sur ETS2

Antigène: ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))

Autre désignation: ETS2 (ETS2 Produits)

Synonymes: anticorps 0123/09, anticorps 0608/07, anticorps 0998/12, anticorps 3520, anticorps CG17077, anticorps CG8705, anticorps D-Ets-2, anticorps D-ets-2, anticorps DMPOINT1A, anticorps Dmel\\CG17077, anticorps E(E2F)3D, anticorps EK3-2, anticorps ETS2, anticorps EY3-1, anticorps Ets, anticorps Ets2, anticorps Ets58AB, anticorps Ets94F, anticorps PNT-P1, anticorps PNTP1, anticorps PNTP2, anticorps POINT, anticorps Pnt, anticorps Pnt-P1, anticorps PntP1, anticorps PntP2, anticorps Pointed-P1, anticorps ets94F, anticorps l(3)07825, anticorps l(3)j1B7, anticorps l(3)s118306, anticorps png, anticorps pnt-P1, anticorps pnt-P2, anticorps pntP2, anticorps pntegfr, anticorps pointed-RC, anticorps ptd, anticorps zgc:92106, anticorps wu:fe02h08, anticorps wu:fk74c05, anticorps AU022856, anticorps Ets-2, anticorps ETS2IT1, anticorps c-ets-2, anticorps pointed, anticorps v-ets avian erythroblastosis virus E26 oncogene homolog 2, anticorps E26 avian leukemia oncogene 2, 3' domain, anticorps ETS proto-oncogene 2, transcription factor, anticorps pnt, anticorps ets2, anticorps Ets2, anticorps ETS2

Sujet: ETS transcriptions factors, such as ETS2, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis. The conserved ETS domain within these proteins is a winged helix-turn-helix DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T of target genes.

Poids moléculaire: 53001

ID gène: 2114

NCBI Accession: NP_005230

UniProt: P15036

Pathways: EGFR Signaling Pathway, Myometrial Relaxation and Contraction